[RDY] YoY Annual Result on 31-Mar-2020 [#FY]

Stock
[RDY] Dr. Reddy's Laboratories Limited
Announcement Date
15-Jun-2020
Financial Year
2020
Quarter
31-Mar-2020 [#FY]
Profit Trend
YoY- 3.74%
Quarter Report
RDY's Result
RDY's Financial Summary
View:
Show?
Annual Result
31/03/23 31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 CAGR
Revenue 245,879,000 214,391,000 189,722,000 174,600,000 153,851,000 142,028,000 140,809,000 9.73%
PBT 60,485,000 32,298,000 28,324,000 18,032,000 22,443,000 14,341,000 14,653,000 26.64%
Tax 15,412,000 8,730,000 9,175,000 -1,466,000 3,648,000 4,535,000 2,614,000 34.39%
NP 45,067,000 23,568,000 17,238,000 19,498,000 18,795,000 9,806,000 12,039,000 24.59%
Tax Rate -25.48% -27.03% -32.39% 8.13% -16.25% -31.62% -17.84% -
Total Cost 200,812,000 190,823,000 172,484,000 155,102,000 135,056,000 132,222,000 128,770,000 7.68%
Ratio Analysis
31/03/23 31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 CAGR
NP Margin 18.33 10.99 9.09 11.17 12.22 6.90 8.55 13.54%
Per Share
31/03/23 31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 CAGR
EPS 271.47 142.08 103.94 117.62 113.28 59.13 72.24 24.67%
EPS Diluted 270.90 141.69 103.65 117.40 113.09 59.01 72.09 24.67%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.